Should Indian hospitals bar Ranbaxy drugs till all-clear sign received from regulators?

shantanu

Shantanu Datta | May 29, 2013



Days after pharma major Ranbaxy courted a soup to escape a soup – and agreed to pay a penalty of $500 million in the United States on charges of fraud – one Mumbai hospital has already put an embargo on drugs manufactured by the company, while several others are reportedly toying with the idea.

While Jaslok Hospital, a leading medical institution in south Mumbai, has already put up a notice advising its doctors to avoid prescribing Ranbaxy drugs, Medanta Medicity’s chairman and managing director Naresh Trehan has said the Gurgaon hospital will “discuss” and “review the situation”, the Business Standard reports.

According to the report, a senior official of Apollo Hospitals said the group was reviewing the situation and would take action, if necessary, while a senior official at Breach Candy, another leading Mumbai hospital, told the paper, “We will be able to give you some update tomorrow.”

Meanwhile, the Indian Medical Association, which represents medical practitioners, has asked the Drug Controller General of India to investigate the quality of drugs manufactured and sold by Ranbaxy in India. (Read the report here).

Ranbaxy had to pay the penalty for selling adulterated drugs with intent to defraud and failing to report that its drugs failed to meet specifications, among other charges.

Under these circumstances, should hospitals and doctors follow Jaslok’s lead and voluntarily issue an embargo on Ranbaxy drugs till medicines manufactured by the company at its units in India get an all-clear signal?

Comments

 

Other News

Maharashtra FDA cracks down on `health supplements`; seizes stock worth Rs 1.39 cr

The Maharashtra Food and Drug Administration (FDA) has issued a comprehensive state wide compliance order tightening regulations governing health supplements, nutraceuticals, sports nutrition products and foods for special dietary and medical purposes. The order, issued by Commissioner of Food Safety, Tu

States face rising fiscal pressure as spending outpaces revenue

States across India are facing increasing fiscal pressures, with revenue expenditure growing faster than revenue receipts since 2022-23, largely driven by rising subsidies and transfers, according to the annual ‘State of State Finances 2026-27’ report released by PRS Legislative Research.

Global value chains and sustainability

When a country’s factories become part of global supply chains, making parts or products that feed into goods sold around the world, the economy usually looks stronger. Output rises, exports grow, and technology improves. But the research behind this article [Bhayana and Nag, 2026] asks a harder qu

Narrative sovereignty in the digital age

In today’s world, competition between countries is not limited to military strength or economic power. It also takes place through the stories countries tell about themselves and the way others describe them. Social media and digital platforms have made this competition faster and more visible. Whe

The hidden cost of voter-ID link with welfare

On October 30, panchayati raj minister Rajiv Ranjan Singh, better known as Lalan Singh, told a national workshop in Delhi that Aadhaar would no longer be the basis for government schemes. His argument seemed simple enough. Aadhaar centres are now in every locality, and anyone can get a card made for anyb

The silent epidemic in the Northeast

In Mizoram, more than nine in ten people can read. Anyone there can find out how HIV spreads and how to protect themselves. Yet Mizoram has the highest rates of HIV patients in the country. If education were enough, this would’ve been solved long ago, but it was not. The answer tells us something a

Upcoming Conferences



-->

Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter